EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
92 hedge funds and large institutions have $227M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+1
Holders Change %
+1.1%
% of All Funds
1.59%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
12
Increased
36
Reduced
25
Closed
11
Calls
$2.22M
Puts
$905K
Net Calls
+$1.32M
Net Calls Change
+$652K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$4.07M |
| 2 |
6CM
683 Capital Management
New York
|
$32.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
$3.09M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
$60.8M |
| 5 |
CA
CHI Advisors
New York
|
$3.43M |
Top Sellers
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
$1.65M |
| 2 |
Morgan Stanley
New York
|
$3.7M |
| 3 |
D.E. Shaw & Co
New York
|
$770K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
$0 |
| 5 |
TI
Telemetry Investments
New York
|
$1.34M |